Board approves revised pricing for preferential share issue for acquisitions
ONEGLOBAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Board approved revised pricing for a preferential issue of 7,06,068 equity shares at Rs 560.13 per share (for MLDPL) and Rs 558.99 per share (for MLPL), face value Rs 10. Shares will be issued as non-cash consideration for acquiring 51 percent stake each in Matrix Labs Diagnocare (Rs 35.98 crore) and Matrix Labs Private Limited (Rs 3.56 crore). BSE directed the price revision per ICDR norms. Addendums to original Share Purchase Agreements signed on 18 September 2026. Total acquisition value unchanged.
Minor dilution from 7.06 lakh new shares; expands presence in diagnostic and healthcare sector; pricing revised per BSE norms.